Learn More
Aspergillus lentulus was first described in the year 2005, and since it cannot be phenotypically distinguished from Aspergillus fumigatus, it is conceivable that earlier descriptions (before 2005) could be attributed to this new species. Currently invasive infections caused by A. lentulus are rare and very few cases have been previously published in(More)
UNLABELLED Data on the epidemiology of infections caused by Clostridium difficile (CDI) in critically ill patients are scarce and center on studies with a limited time framework and/or epidemic outbreaks. OBJECTIVE To describe the characteristics and risk factors of critically ill patients admitted to the ICU with CDI, as well as the treatments used for(More)
Medidas de prevención de la candidiasis invasora en el paciente crítico no neutropénico Prevention of invasive candidiasis in the critically ill non neutropenic patient Prevention of invasive candidiasis (IC) in the setting of critically ill non neutrope-nic patients should be based on evidenced-based recommendations, namely improved hand hygiene, optimal(More)
las últimas décadas, la incidencia de la infec-ción fúngica invasora (IFI) se ha incrementado en los pacientes críticos no neutropénicos de las Unidades de Cuidados Intensivos (UCIs), aumentando la morbimortali-dad asociada a este tipo de patología. La candidiasis inva-sora (CI) es la infección más prevalente [53]. como ravuconazol, posaconazol,(More)
BACKGROUND Patients infected with influenza A (H1N1)pdm09 virus requiring admission to the ICU remain an important source of mortality during the influenza season. The objective of the study was to assess the impact of a delay in diagnosis of community-acquired influenza A (H1N1)pdm09 virus infection on clinical outcome in critically ill patients admitted(More)
Anidulafungin: a new therapeutic approach in antifungal therapy. Pharmacology of anidulafungin Anidulafungin is a new echinocandin antifungal agent which inhibits ß-1,3-D-glucan synthase and disrupts fungal cell-wall synthesis. It has marked antifungal activity against Candida spp. and Aspergillus spp., including amphotericin B and triazole resistant(More)